| Nutritional medicine as mainstream in psychiatry J Sarris, AC Logan, TN Akbaraly, GP Amminger, V Balanzá-Martínez, ... The Lancet Psychiatry 2 (3), 271-274, 2015 | 690 | 2015 |
| Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta‐analysis C Bourne, Ö Aydemir, V Balanzá‐Martínez, E Bora, S Brissos, ... Acta Psychiatrica Scandinavica 128 (3), 149-162, 2013 | 669 | 2013 |
| Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up R Tabarés-Seisdedos, V Balanzá-Martínez, J Sánchez-Moreno, ... Journal of affective disorders 109 (3), 286-299, 2008 | 358 | 2008 |
| Efficacy of functional remediation in bipolar disorder: a multicenter randomized controlled study C Torrent, CM Bonnin, A Martínez-Arán, J Valle, BL Amann, ... American Journal of Psychiatry 170 (8), 852-859, 2013 | 356 | 2013 |
| Lifestyle behaviours during the COVID‐19–time to connect V Balanzá–Martínez, B Atienza–Carbonell, F Kapczinski, RB De Boni Acta Psychiatrica Scandinavica 141 (5), 399, 2020 | 355 | 2020 |
| The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal S Brissos, MR Veguilla, D Taylor, V Balanzá-Martinez Therapeutic advances in psychopharmacology 4 (5), 198-219, 2014 | 320 | 2014 |
| Neurocognitive endophenotypes (endophenocognitypes) from studies of relatives of bipolar disorder subjects: a systematic review V Balanzá-Martínez, C Rubio, G Selva-Vera, A Martinez-Aran, ... Neuroscience & Biobehavioral Reviews 32 (8), 1426-1438, 2008 | 273 | 2008 |
| Specificity of cognitive deficits in bipolar disorder versus schizophrenia: a systematic review C Daban, A Martinez-Aran, C Torrent, R Tabarés-Seisdedos, ... Psychotherapy and psychosomatics 75 (2), 72-84, 2006 | 268 | 2006 |
| Staging systems in bipolar disorder: an I nternational S ociety for B ipolar D isorders T ask F orce R eport F Kapczinski, PVS Magalhães, V Balanzá‐Martinez, VV Dias, S Frangou, ... Acta psychiatrica scandinavica 130 (5), 354-363, 2014 | 245 | 2014 |
| Short‐term neuropsychiatric outcomes and quality of life in COVID‐19 survivors R Mendez, V Balanzá‐Martínez, SC Luperdi, I Estrada, A Latorre, ... Journal of internal medicine 290 (3), 621-631, 2021 | 229 | 2021 |
| Persistent cognitive dysfunctions in bipolar I disorder and schizophrenic patients: a 3-year follow-up study V Balanzá-Martínez, R Tabarés-Seisdedos, G Selva-Vera, ... Psychotherapy and psychosomatics 74 (2), 113-119, 2005 | 225 | 2005 |
| Inverse and direct cancer comorbidity in people with central nervous system disorders: a meta-analysis of cancer incidence in 577,013 participants of 50 observational studies F Catalá-López, M Suárez-Pinilla, P Suárez-Pinilla, JM Valderas, ... Psychotherapy and psychosomatics 83 (2), 89-105, 2014 | 219 | 2014 |
| The assessment of lifestyle changes during the COVID-19 pandemic using a multidimensional scale V Balanzá-Martínez, F Kapczinski, T de Azevedo Cardoso, ... Revista de psiquiatria y salud mental 14 (1), 16-26, 2021 | 209 | 2021 |
| Neurocognitive impairment in bipolar patients with and without history of psychosis R Tabares-Seisdedos, M Salamero, C Daban, V Balanza-Martinez J Clin Psychiatry 69, 233-239, 2008 | 193 | 2008 |
| The clinical implications of cognitive impairment and allostatic load in bipolar disorder E Vieta, D Popovic, AR Rosa, B Solé, I Grande, BN Frey, A Martinez-Aran, ... European Psychiatry 28 (1), 21-29, 2013 | 178 | 2013 |
| Pharmacological approaches in bipolar disorders and the impact on cognition: a critical overview VV Dias, V Balanzá‐Martinez, MG Soeiro‐de‐Souza, RA Moreno, ... Acta Psychiatrica Scandinavica 126 (5), 315-331, 2012 | 163 | 2012 |
| Neurocognition in bipolar disorders—a closer look at comorbidities and medications V Balanzá-Martínez, G Selva, A Martínez-Arán, J Prickaerts, J Salazar, ... European Journal of Pharmacology 626 (1), 87-96, 2010 | 162 | 2010 |
| Psychiatric comorbidity at the time of diagnosis in adults with ADHD: the CAT study B Piñeiro-Dieguez, V Balanzá-Martínez, P García-García, B Soler-López, ... Journal of attention disorders 20 (12), 1066-1075, 2016 | 157 | 2016 |
| Ketogenic diet as a metabolic therapy for mood disorders: evidence and developments E Brietzke, RB Mansur, M Subramaniapillai, V Balanzá-Martínez, ... Neuroscience & Biobehavioral Reviews 94, 11-16, 2018 | 154 | 2018 |
| Therapeutic use of omega-3 fatty acids in bipolar disorder V Balanzá-Martínez, GR Fries, GD Colpo, PP Silveira, AK Portella, ... Expert review of neurotherapeutics 11 (7), 1029-1047, 2011 | 152 | 2011 |
